These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27520400)

  • 1. Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial.
    Bo S; Ponzo V; Ciccone G; Evangelista A; Saba F; Goitre I; Procopio M; Pagano GF; Cassader M; Gambino R
    Pharmacol Res; 2016 Sep; 111():896-905. PubMed ID: 27520400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial.
    Bo S; Ponzo V; Evangelista A; Ciccone G; Goitre I; Saba F; Procopio M; Cassader M; Gambino R
    Acta Diabetol; 2017 May; 54(5):499-507. PubMed ID: 28238190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial.
    Seyyedebrahimi S; Khodabandehloo H; Nasli Esfahani E; Meshkani R
    Acta Diabetol; 2018 Apr; 55(4):341-353. PubMed ID: 29357033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial.
    Bo S; Gambino R; Ponzo V; Cioffi I; Goitre I; Evangelista A; Ciccone G; Cassader M; Procopio M
    Nutr Diabetes; 2018 Sep; 8(1):51. PubMed ID: 30237505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial.
    Bo S; Ciccone G; Castiglione A; Gambino R; De Michieli F; Villois P; Durazzo M; Cavallo-Perin P; Cassader M
    Curr Med Chem; 2013; 20(10):1323-31. PubMed ID: 23298135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol supplementation decreases blood glucose without changing the circulating CD14
    Khodabandehloo H; Seyyedebrahimi S; Esfahani EN; Razi F; Meshkani R
    Nutr Res; 2018 Jun; 54():40-51. PubMed ID: 29914666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Patients With Type 2 Diabetes Mellitus.
    Imamura H; Yamaguchi T; Nagayama D; Saiki A; Shirai K; Tatsuno I
    Int Heart J; 2017 Aug; 58(4):577-583. PubMed ID: 28701674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of orlistat treatment and placebo in obese type 2 diabetic patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; D'Angelo A; Fogari E; Palumbo I; Randazzo S; Cicero AF
    Expert Opin Pharmacother; 2010 Aug; 11(12):1971-82. PubMed ID: 20569086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial.
    Soleimani A; Taghizadeh M; Bahmani F; Badroj N; Asemi Z
    Clin Nutr; 2017 Feb; 36(1):79-84. PubMed ID: 26611718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Curcuminoids Plus Piperine on Glycemic, Hepatic and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Placebo-Controlled Trial.
    Panahi Y; Khalili N; Sahebi E; Namazi S; Simental-Mendía LE; Majeed M; Sahebkar A
    Drug Res (Stuttg); 2018 Jul; 68(7):403-409. PubMed ID: 29458218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial.
    Ebrahimpour Koujan S; Gargari BP; Mobasseri M; Valizadeh H; Asghari-Jafarabadi M
    Phytomedicine; 2015 Feb; 22(2):290-6. PubMed ID: 25765835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenium Supplementation Affects Insulin Resistance and Serum hs-CRP in Patients with Type 2 Diabetes and Coronary Heart Disease.
    Farrokhian A; Bahmani F; Taghizadeh M; Mirhashemi SM; Aarabi MH; Raygan F; Aghadavod E; Asemi Z
    Horm Metab Res; 2016 Apr; 48(4):263-8. PubMed ID: 26743526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol.
    Wicklow B; Wittmeier K; T' Jong GW; McGavock J; Robert M; Duhamel T; Dolinsky VW
    Biochem Cell Biol; 2015 Oct; 93(5):522-30. PubMed ID: 26305052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
    Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease.
    Hoseini A; Namazi G; Farrokhian A; Reiner Ž; Aghadavod E; Bahmani F; Asemi Z
    Food Funct; 2019 Sep; 10(9):6042-6051. PubMed ID: 31486447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
    Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
    Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial.
    Adibian M; Hodaei H; Nikpayam O; Sohrab G; Hekmatdoost A; Hedayati M
    Phytother Res; 2019 May; 33(5):1374-1383. PubMed ID: 30864188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus.
    Wong RH; Nealon RS; Scholey A; Howe PR
    Nutr Metab Cardiovasc Dis; 2016 May; 26(5):393-9. PubMed ID: 27105868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.
    Faghihzadeh F; Adibi P; Rafiei R; Hekmatdoost A
    Nutr Res; 2014 Oct; 34(10):837-43. PubMed ID: 25311610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.